⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 3, 2024Open Access

Conditional deletion of CEACAM1 causes hepatic stellate cell activation

Harrison T. Muturi Hilda E. Ghadieh Suman Asalla Sumona Ghosh Lester Stefaan Verhulst Hannah L. Stankus Sobia Zaidi Raziyeh Abdolahipour Getachew D. Belew Leo A. van Grunsven Scott L. Friedman Robert F. Schwabe Terry D. Hinds Sonia M. Najjar

View Full Paper

Ask AI

Bookmark

Share

Abstract

Hepatic CEACAM1 expression declines with advanced hepatic fibrosis stage in patients with MASH. Global and hepatocyte-specific deletions of

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Muturi et al. (2024) studied this question.

synapsesocial.com/papers/68e708e7b6db6435876830a9 https://doi.org/10.1101/2024.04.02.586238

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation2024 · 16 citations
2Cell-specific regulation of insulin action and hepatic fibrosis by CEACAM12024 · 7 citations
3Loss of <scp>CEACAM1</scp> in hepatocytes causes hepatic fibrosis2024 · 19 citations
4Low Hepatic CEACAM1 Tethers Metabolic Dysfunction Steatohepatitis to Atherosclerosis2025
5Hepatocyte-specific CCAAT/enhancer binding protein α restricts liver fibrosis progression2024 · 34 citations